Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay
January 07, 2019 at 18:40 PM EST
Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
